ECU launches spin-off for commercial telemedicine

Article

ECU launches spin-off for commercial telemedicineEast Carolina University has teamed with a group of private investors to establish Telemedicine Technologies, a commercial entity based in Greenville, NC, that offers training, consulting, and

ECU launches spin-off for commercial telemedicine

East Carolina University has teamed with a group of private investors to establish Telemedicine Technologies, a commercial entity based in Greenville, NC, that offers training, consulting, and product-development services. The spin-off grew out of expanding interest in the university's telemedicine program, under the direction of Dave Balch, who is also technology manager for Telemedicine Technologies.

What makes Telemedicine Technologies different from most university spin-offs is its emphasis on helping to build the industry, according to Bob Watson, business development manager. The company plans to work closely with the university and its school of medicine, local hospitals, and medical and health professionals. It has also assembled a consortium of medical, communications, and information resources to assess, design, and implement new technologies and systems. Its strategic partners already include 3Com, Sprint Healthcare, and Welch Allyn.

"In addition to training, consulting, and integration services, we will develop and transfer telemedicine, informatics, and instrument technology from research to production projects," Watson said.

The goal is to offer a testbed for new product development and assessment. In return, the company will retain royalties on those technologies that become commercial products.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.